A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

KCNT1-Related Epilepsy

Interventions

DRUG

ABS-1230

DRUG

Placebo

Trial Locations (1)

RECRUITING

Scientia Clinical Research, Sydney